News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Menarini & Insilico Medicine's Global License for KAT6 Inhibitor in Breast Cancer Treatment
Friday, January 05, 2024The Menarini Group a major international pharmaceutical and diagnostics company in collaboration with its subsidiary Stemline Therapeutics and Insilico Medicine a clinicalstage AIdriven biotechnology firm
Apertura Gene Therapy Reveals Newly Engineered AAV Capsids Tailored for Human Transferrin Receptor 1 in Advancing Neurological Gene Therapy Delivery
Friday, January 05, 2024Apertura Gene Therapy a biotechnology company has introduced its proprietary engineered AdenoAssociated Virus capsids designed to target the human Transferrin Receptor
Ribo and Boehringer Ingelheim Collaborate to Create Innovative Treatments for Individuals With Liver Diseases
Thursday, January 04, 2024Suzhou Ribo Life Science Co Ltd and Ribocure AB have jointly announced a collaboration with Boehringer Ingelheim to develop novel treatments for nonalcoholic or metabolic dysfunctionassociated steatohepatitis
Tome Biosciences Successfully Acquires Replace Therapeutics
Wednesday, January 03, 2024Tome Biosciences Inc has recently completed the acquisition of Replace Therapeutics Inc a privatelyheld biotechnology company specializing in a novel programmable genomic integration method designed for the insertion
Natco Pharma USA Successfully Integrates DASH Pharmaceuticals, Strengthening Strategic Presence in the United States
Wednesday, January 03, 2024Natco Pharma Limited an Indian pharmaceutical company primarily focused on research and development RD has officially declared the transition of DASH Pharmaceuticals to Natco Pharma USA
Cell BioEngines and Miltenyi Bioindustry Establish Collaboration for Manufacturing Hematopoietic Cell Therapy in Clinical Program
Tuesday, January 02, 2024Cell BioEngines Inc a biotechnology company in the clinical stage has revealed a partnership with Miltenyi to progress the development and manufacturing of its expanded hematopoietic stem cell transplantation
Atom Bioscience Secures FDA IND Clearance to Initiate Clinical Trial for ABP-745 Targeting Acute Gout
Tuesday, January 02, 2024Atom Bioscience specifically Jiangsu Atom Bioscience and Pharmaceutical Co Ltd a biotechnology company in the clinical stage is making strides in the development of treatments for inflammatory and metabolic diseases
Roche Has Concluded a Definitive Agreement to Purchase Lumiradx's Point of Care Technology, Bringing Together Various Diagnostic Modalities on a Unified Platform
Saturday, December 30, 2023Roche has formally entered into a definitive agreement to acquire specific components of the LumiraDx group NASDAQ GS LMDX related to LumiraDxs Point of Care technology
Nectin Therapeutics Advances Current Clinical Trial and Expands Trial Sites to Include Israel
Wednesday, December 27, 2023Nectin Therapeutics Ltd a biotechnology company focusing on the development of targeted immunotherapies to overcome resistance to approved immune oncology treatments has made notable progress in its Phase clinical trial
European Commission Approves Marketing Authorization for Vueway® (Gadopiclenol)
Saturday, December 23, 2023Bracco Imaging SpA has obtained marketing approval from the European Commission for Vueway a new contrast agent for magnetic resonance imaging The approval backed by the Committee
